heart failure

News

Astellas brings its first digital health product to US

Astellas is ready to launch its first digital health offering in the US, a toolkit dedicated to providing at-home monitoring for people living with heart failure.

News

Kerendia works in heart failure, but how might it be used?

Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure in the FINEARTS-HF study, setting up regulatory approvals, but th

News

Bayer's finerenone clears key heart failure trial

At the start of this year, Bayer said there were two important trial readouts for the company to deliver near-term growth this year as it rebuilds its pipeline – and both have now delivered

News

Lilly gets first heart outcomes readout with tirzepatide

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefi

News

Study finds wearables deliver key insights in heart disease

Off-the-shelf consumer wearables have shown a benefit when used to monitor the response to treatment in patients with atrial fibrillation (AF) and heart failure (HF).

News

Wearable device ‘may prevent heart failure hospitalisation’

Monitoring of heart failure patients in their homes using a wearable developed by Analog Devices Inc (ADI) has shown in a new study that it may be able to reduce costly ho

Astellas brings its first digital health product to US

Kerendia works in heart failure, but how might it be used?

Bayer's finerenone clears key heart failure trial

Lilly gets first heart outcomes readout with tirzepatide

Study finds wearables deliver key insights in heart disease

Wearable device ‘may prevent heart failure hospitalisation’

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

heart failure

Editor's Picks